Issue date: April 2011.
Everolimus for the second-line treatment of advanced renal cell carcinoma by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2011. Publication and catalogue information, links to buy online and reader comments.